Bill

Bill > HB1652


PA HB1652

PA HB1652
Further providing for Newborn Child Screening and Follow-up Program.


summary

Introduced
06/24/2025
In Committee
06/24/2025
Crossed Over
Passed
Dead

Introduced Session

2025-2026 Regular Session

Bill Summary

Amending the act of September 9, 1965 (P.L.497, No.251), entitled "An act requiring physicians, hospitals and other institutions to administer or cause to be administered tests for genetic diseases upon infants in certain cases," further providing for Newborn Child Screening and Follow-up Program.

AI Summary

This bill amends the Newborn Child Testing Act to add Gaucher disease to the list of conditions that must be screened for in newborn children. Gaucher disease is a rare genetic disorder that affects the body's ability to break down certain fatty substances, potentially leading to serious health complications. The bill requires the Pennsylvania Department of Health, with approval from the Newborn Screening and Follow-up Technical Advisory Board, to include Gaucher disease screening as part of its existing newborn screening program. The goal of this screening is to help healthcare providers identify potential health risks early and determine if treatment or other services are necessary to prevent intellectual disability, physical disability, or death. The bill will go into effect 60 days after its enactment, which will give healthcare providers and laboratories time to prepare to implement the new screening requirement.

Committee Categories

Health and Social Services

Sponsors (20)

Last Action

Laid on the table (on 11/18/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...